Three cohort studies have identified a risk reduction with prophylactic bilateral adnexectomy in women with germ line BRCA1 or 2 mutations by comparing the incidence of ovarian cancer in the control group to the incidence of primary peritoneal carcinoma in the prophylactic adnexectomy group. This evidence concerns the gene BRCA1 and peritoneal carcinoma.